Sveinbjörn Gizurarson

Sveinbjorn is a professor in clinical pharmacokinetics and toxicology at the
University of Iceland. He is also an Honorary lecturer at Kamuzu University of Health Sciences in Malawi and the Honorary Consul for Malawi in Iceland. Sveinbjorn has one drug on the market, Nayzilam, that took 20 years to develop and 12 years through phases I-III. He has worked as a consultant for multiple companies around the world, mainly on intranasal drug and vaccine
development.